These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17092549)

  • 1. The pattern of CD98 expression is different between uterine serous papillary carcinoma and endometrioid endometrial carcinoma.
    Monaghan H; Williams AR
    Gynecol Oncol; 2007 Jan; 104(1):264-5. PubMed ID: 17092549
    [No Abstract]   [Full Text] [Related]  

  • 2. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.
    Santin AD; Diamandis EP; Bellone S; Soosaipillai A; Cane S; Palmieri M; Burnett A; Roman JJ; Pecorelli S
    Clin Cancer Res; 2005 May; 11(9):3320-5. PubMed ID: 15867230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zone Formation of Lymphocyte Infiltration at the Invasive Front Results in the Prolonged Survival of Individuals With Endometrial Serous Carcinoma and Endometrioid Carcinoma With Serous Component.
    Miyamoto M; Takano M; Tsuda H; Ishibashi H; Soyama H; Matsuura H; Sakamoto T; Aoyama T; Iwahashi H; Furuya K
    Anticancer Res; 2019 Apr; 39(4):2085-2089. PubMed ID: 30952753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.
    Santin AD; Diamandis EP; Bellone S; Marizzoni M; Bandiera E; Palmieri M; Papasakelariou C; Katsaros D; Burnett A; Pecorelli S
    Am J Obstet Gynecol; 2006 May; 194(5):1296-302. PubMed ID: 16647913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of clusterin according to histological type of endometrial carcinoma.
    Ahn HJ; Bae J; Lee S; Ko JE; Yoon S; Kim SJ; Sakuragi N
    Gynecol Oncol; 2008 Aug; 110(2):222-9. PubMed ID: 18514801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local immune response in serous papillary carcinoma of the endometrium.
    Tamiolakis D; Venizelos J; Lambropoulou M; Nikolaidou S; Tsikouras P; Jivannakis T; Papadopoulos N
    Histol Histopathol; 2005 Apr; 20(2):403-8. PubMed ID: 15736043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cDNA microarray analysis and immunohistochemistry reveal a distinct molecular phenotype in serous endometrial cancer compared to endometrioid endometrial cancer.
    Chen Y; Yao Y; Zhang L; Li X; Wang Y; Zhao L; Wang J; Wang G; Shen D; Wei L; Zhao J
    Exp Mol Pathol; 2011 Aug; 91(1):373-84. PubMed ID: 21540026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Uterine papillary serous carcinoma--a different kind of tumor].
    Steinman N; Avni A
    Harefuah; 1999 May; 136(10):810-2. PubMed ID: 10955120
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential expression of WT-1 in serous carcinomas in the peritoneum with or without associated serous carcinoma in endometrial polyps.
    Euscher ED; Malpica A; Deavers MT; Silva EG
    Am J Surg Pathol; 2005 Aug; 29(8):1074-8. PubMed ID: 16006803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial carcinoma in one horn of a bicornuate uterus.
    Moore JR; Davidson SA; Singh M
    Gynecol Oncol; 2004 Dec; 95(3):729-32. PubMed ID: 15581992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WT-1 in ovarian and endometrioid serous carcinoma: a meta-analysis.
    Heatley MK
    Histopathology; 2005 Apr; 46(4):468. PubMed ID: 15810962
    [No Abstract]   [Full Text] [Related]  

  • 12. Wilms' tumor gene 1 (WT1) in endometrial carcinoma.
    Coosemans A; Moerman P; Verbist G; Maes W; Neven P; Vergote I; Van Gool SW; Amant F
    Gynecol Oncol; 2008 Dec; 111(3):502-8. PubMed ID: 18929401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMP-2, TIMP-1, E-cadherin, and beta-catenin expression in endometrial serous carcinoma compared with low-grade endometrial endometrioid carcinoma and proliferative endometrium.
    Shaco-Levy R; Sharabi S; Piura B; Sion-Vardy N
    Acta Obstet Gynecol Scand; 2008; 87(8):868-74. PubMed ID: 18607832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for distinguishing low-grade endometrioid and serous carcinomas of endometrium.
    Garg K; Soslow RA
    Adv Anat Pathol; 2012 Jan; 19(1):1-10. PubMed ID: 22156830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-2 (MMP-2): a major player in the progression of systemic malignancies besides endometrial serous carcinomas.
    Kapoor S
    Acta Obstet Gynecol Scand; 2008; 87(11):1259. PubMed ID: 18763172
    [No Abstract]   [Full Text] [Related]  

  • 16. Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas.
    Siami K; McCluggage WG; Ordonez NG; Euscher ED; Malpica A; Sneige N; Silva EG; Deavers MT
    Am J Surg Pathol; 2007 Nov; 31(11):1759-63. PubMed ID: 18059234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of matrix metalloproteinases-2, -7 and -9 and beta-catenin in high grade endometrial carcinoma.
    Monaghan H; MacWhinnie N; Williams AR
    Histopathology; 2007 Feb; 50(3):348-57. PubMed ID: 17257130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathology of endometrial carcinoma].
    Shiozawa T; Konishi I
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():273-8. PubMed ID: 15535250
    [No Abstract]   [Full Text] [Related]  

  • 19. [Endometrial carcinoma and precursor lesions].
    Djordjević B; Stanojević Z
    Srp Arh Celok Lek; 2007; 135(3-4):230-4. PubMed ID: 17642468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serous EIC as an early form of uterine papillary serous carcinoma: recent progress in understanding its pathogenesis and current opinions regarding pathologic and clinical management.
    Zheng W; Schwartz PE
    Gynecol Oncol; 2005 Mar; 96(3):579-82. PubMed ID: 15721397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.